Senators question tobacco firms on lobbying in wake of new FDA policy

Why this matters: political developments that affect policy direction and public trust.

A group of six Democratic senators sent letters to two tobacco companies on Thursday, asking for details on their dealings with the Trump administration in the wake of the Food and Drug Administration (FDA) easing restrictions on vapes. Last month, the FDA granted marketing authorization to four fla